Trial Details

TERMINATED
Basic Information
Clinical ID c3922
Identifier NCT01318993
Trial Title Open-Label Extension Study of GSK1605786A
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: GSK1605786A
Participant Information
Sponsor GlaxoSmithKline
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2011-04-01
Primary Completion Date 2013-09-01
Completion Date 2013-10-29